Hatteras Venture Partners II

Hatteras Venture Partners II
280 S Mangum St
Suite 510
Durham, NC 27701
United States

Open Map

Phone

Website

Industry

VCID: 110884

Profile

Also known as

HVP II

Registration country

Investment activity status

Active investor

Fund manager

Vintage

2004

Country from which managed

United States

Fund type

Funding

USD 35,000,000 (31 Dec 2004)

Investments

	Country	Notes
Delenex Therapeutics AG	Switzerland	N/A
Nereus Pharmaceuticals Inc	United States	N/A
ESBATech AG Switzerland based Biomedical Research Unit of Alcon	Switzerland	N/A
Newron Pharmaceuticals SpA	Italy	N/A
Kolltan Pharmaceuticals Inc Oncology therapeutics company, develops monoclonal antibody drugs targeting receptor tyrosine kinases.	United States	N/A
Precimed Group A leading technology-driven supplier to the orthopaedic industry	Switzerland	N/A
Lux Biosciences Inc Clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases.	United States	N/A
Zosano Pharma Inc	United States	N/A
Micardia Corp	United States	N/A
Anthera Pharmaceuticals Inc	United States	N/A Active
Asthmatx Inc	United States	N/A
Mpex Pharmaceuticals Inc	United States	N/A
BRAHMS GmbH	Germany	N/A
mtm laboratories AG	Germany	N/A
Broncus Technologies Inc Developer of interventional bronchoscopy devices for the treatment of chronic lung diseases.	United States	N/A
Nabriva Therapeutics AG	Austria	N/A